142 results on '"Brennan, D.C."'
Search Results
2. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation
3. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis
4. Perioperative Complications After Living Kidney Donation: A National Study
5. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients
6. Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States
7. Graft-Versus-Host Disease After Simultaneous Pancreas–Kidney Transplantation: A Case Report and Review of the Literature
8. The Impact of Medicare’s Lifetime Immunosuppression Coverage on Racial Disparities in Kidney Graft Survival
9. Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials
10. Delayed Graft Function in the Kidney Transplant
11. A Risk Prediction Model for Delayed Graft Function in the Current Era of Deceased Donor Renal Transplantation
12. BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results
13. Focal C4d+ in Renal Allografts Is Associated with the Presence of Donor-Specific Antibodies and Decreased Allograft Survival
14. Predictive Ability of Pretransplant Comorbidities to Predict Long-Term Graft Loss and Death
15. Income-Related Disparities in Kidney Transplant Graft Failures Are Eliminated by Medicare’s Immunosuppression Coverage
16. Monozygotic Transplantation: Concerns and Opportunities
17. Patient and Graft Survival Implications of Simultaneous Pancreas Kidney Transplantation From Old Donors
18. Polyclonal antibodies in immunosuppression
19. National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection
20. Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
21. Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data
22. Pneumococcal 13-Valent Conjugate Vaccine (Prevnar 13)-Associated Immune Thrombocytopenic Purpura in a Renal Transplant Recipient: A Case Report
23. Accuracy of Inpatient International Classification of Diseases, Ninth Revision, Clinical Modification Coding for Cytomegalovirus After Kidney Transplantation
24. Incidence, Risk Factors, and Outcomes of Delayed-Onset Cytomegalovirus Disease in a Large, Retrospective Cohort of Heart Transplant Recipients
25. Retransplant after loss to polyomavirus-associated nephropathy is an option: polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations
26. Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant
27. Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
28. Smoking association with influenza infection in renal transplant recipients
29. Deregulation and Contestability in Grain Transport
30. Economics of Throughput and Transport Bottlenecks in Grain Distribution Systems
31. Maintenance Steroid Therapy for Kidney Recipients—Not Ready for Relegation
32. Kidney Transplantation: Principles and Practice
33. Didactic Lessons from the Serum Lactate Dehydrogenase Posttransplant: A Clinical Vignette
34. Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients
35. BK Virus Infection in Transplant Recipients: An Overview and Update
36. Role of HLA C7 in BKV Infections
37. The Incidence and Costs of Sepsis and Pneumonia Before and After Renal Transplantation in the United States
38. Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
39. Smoking association with influenza infection in renal transplant recipients.
40. The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants From Sibling Donors
41. Leukocyte response to thymoglobulin or Atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients
42. Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation
43. Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets
44. High risk kidney transplant rejection treatment: cost savings from thymoglobulin
45. Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry
46. Down regulation of in vivo and in vitro T cell responses post cytomegalovirus immune globulin intravenous (human) administration in sensitized renal transplant candidates
47. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in a renal transplant patient
48. Transplant recipients as organ donors: The domino transplant
49. Sensitization to HLA antigens in islet recipients with failing transplants
50. Comparison of transplanted islets in patients with functioning versus nonfunctioning allografts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.